Premium
Hong Kong-based TR Capital is looking to make more healthcare investments in India, a top executive said, as the private equity firm that specialises in secondaries transactions seeks to expand its exposure to the booming sector. The firm has already backed biotechnology, bulk drugs and medical devices companies in India. And ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
